HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese

International Journal of Cancer

Volumn 136, Issue 3, 2015, Pages 678-687

  Chin, Yoon Ming ^a,b   Mushiroda, Taisei ^a   Takahashi, Atsushi ^a   Kubo, Michiaki ^a   Krishnan, Gopala ^c,n   Yap, Lee Fah ^c,d,f   Teo, Soo Hwang ^d,f   Lim, Paul Vey Hong ^e   Yap, Yoke Yeow ^d,f,g   Pua, Kin Choo ^h,l   Kamatani, Naoyuki ^a   Nakamura, Yusuke ⁱ   Sam, Choon Kook ^j   Khoo, Alan Soo Beng ^h,k   Subathra, S ^l   Punithavati, N ^l   Tan, B S ^l   Ee, Y S ^l   Ong, L M ^l   Hamid, R A ^l   Goh, M ^l   Quah, J C T ^l   Lim, J ^l   Dipak, B D ^d   Deepak, R ^d   Lau, F N ^d   Kam, P V ^d   Shri Devi, S ^d,h   Ong, C A ^m   Lum, C L ^m   Ahmad, N A ^m   Halimuddin, S ^m   Somasundran, M ^m   Kam, A ^m   Wodjin, M ^m   Subramaniam, S K ^c   Tiong, T S ^c   Tan, T Y ^c   Sim, U H ^c   Tharumalingam, T W ^c   Norlida, D ^c   Zulkarnaen, M ^c   Lai, W H ^c   Bustam, A Z ⁿ   Marniza, S ⁿ   Shahfinaz, P ⁿ   Hashim, O ⁿ   Shamshinder, S ⁿ   Prepageran, N ⁿ   Looi, L M ⁿ   Rahmat, O ⁿ   Amin, J ⁿ   Maznan, J ⁿ   Hassan, S ^o   Biswal, B ^o   Munirah, A ^h   Subasri, A ^h   Tan, L P ^h   Kumaran, N M ^h   Nurul Ashikin, M S ^h   Nursyazwani, M S ^h   Norhasimah, B ^h   Sasela Devi, R ^h   Koh, C Y ^h   Ng, Ching Ching ^a,b,n   more..

^a RIKEN   (Japan)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^e Tung Shin Hospital   (Malaysia)

^f UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^g HOSPITAL KUALA LUMPUR   (Malaysia)

^h HOSPITAL PULAU PINANG   (Malaysia)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^k INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^l INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^m HOSPITAL UNIVERSITI SAINS MALAYSIA   (Malaysia)

ⁿ UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^o Department of Otorhinolaryngology Head and Neck Surgery   (Malaysia)

more..

Author keywords

GWAS; HLA A; Imputation; Malaysian Chinese; Nasopharyngeal carcinoma

Indexed keywords

AMINO ACID; HLA A ANTIGEN; T LYMPHOCYTE RECEPTOR;

5' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; BINDING SITE; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; DISEASE ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENETIC ASSOCIATION; GENOME ANALYSIS; HLA A GENE; HUMAN; MALAYSIAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NASOPHARYNX CARCINOMA; ONCOGENE; PROMOTER REGION; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALAYSIA; NASOPHARYNX TUMOR;

AMINO ACIDS; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA-A ANTIGENS; HUMANS; MALAYSIA; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84911005348     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29035     Document Type: Article

References (44)

1. Curado MP, Edwards B, Shin HR, et al., eds. Cancer incidence in five continents, vol. IX. International Agency for Research on Cancer, 2013.
2. Zainal Ariffin O, Nor Saleha IT, et al., eds. National Cancer Registry Report 2007, Ministry of Health, Malaysia, 2011.
3. Devi BC, Pisani P, Tang TS, et al. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island. Cancer Epidemiol Biomarkers Prev 2004;13:482-6.
4. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 1985;36: 545-7.
5. Armstrong RW, Armstrong MJ, Mimi CY, et al. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983;43:2967-70.
6. Cheng Y-J, Hildesheim A, Hsu M-M, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999;10:201-7.
7. He Y, Zhou G, Zhai Y, et al. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet 2005;42:172-6.
8. Jia W-H, Pan Q-H, Qin H-D, et al. A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 2009;30:2031-6.
9. Cho E-Y, Hildesheim A, Chen C-J, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003; 12:1100-4.
10. Yew PY, Mushiroda T, Kiyotani K, et al. Identification of a functional variant in SPLUNC1 associated with nasopharyngeal carcinoma susceptibility among Malaysian Chinese. Mol Carcinogen 2012;51 Suppl 1:E74-82.
11. Simon M, Pawlotsky Y, Bourel M, et al. [Letter: Idiopathic hemochromatosis associated with HLA 3 tissular antigen]. La Nouvelle presse medicale 1975;4:1432.
12. Tse KP, Su WH, Chang KP, et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Human Genet 2009; 85:194-203.
13. Bei JX, Li Y, Jia WH, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010; 42:599-603.
14. Tang M, Lautenberger JA, Gao X, et al. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet 2012;8: e1003103.
15. Lu CC, Chen JC, Tsai ST, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using highresolution microsatellite mapping. Int J Cancer 2005;115:742-6.
16. Hildesheim A, Apple RJ, Chen C-J, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002;94:1780-9.
17. Goldsmith D, West T, Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. Clin Otolaryngol Allied Sci 2002;27:61-7.
18. Tang M, Zeng Y, Poisson A, et al. Haplotypedependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun 2010;11:334-42.
19. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166-72.
20. Ng CC, Yew PY, Puah SM, et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Human Genet 2009;54:392-7.
21. Ausubel FM. Current protocols in molecular biologyed. New York: Greene Pub. Associates and Wiley-Interscience, 1987.
22. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
23. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Human Genet 2007;81:559-75.
24. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39:906-13.
25. Choi Y, Sims GE, Murphy S, et al. Predicting the functional effect of amino acid substitutions and indels. PloS One 2012;7:e46688.
26. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-81.
27. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-9.
28. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40:D930-4.
29. Matys V, Fricke E, Geffers R, Goßling E, et al. TRANSFACVR: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003;31: 374-8.
30. Portales-Casamar E, Thongjuea S, Kwon AT, et al. JASPAR 2010: the greatly expanded openaccess database of transcription factor binding profiles. Nucleic Acids Res 2010;38:D105-110.
31. Berger MF, Badis G, Gehrke AR, et al. Variation in homeodomain DNA binding revealed by highresolution analysis of sequence preferences. Cell 2008;133:1266-76.
32. Badis G, Berger MF, Philippakis AA, et al. Diversity and complexity in DNA recognition by transcription factors. Science 2009;324: 1720-3.
33. Yang TP, Beazley C, Montgomery SB, et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 2010;26:2474-6.
34. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009; 325:1246-50.
35. Nica AC, Parts L, Glass D, et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 2011;7:e1002003.
36. Gilchrist M, Thorsson V, Li B, et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006;441: 173-8.
37. Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Molecular Oncology 2007;1:19-25.
38. Matsui M, Hioe CE, Frelinger JA. Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc Natl Acad Sci USA 1993;90:674-8.
39. Salter RD, Benjamin RJ, Wesley PK, et al. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 1990;345: 41-6.
40. Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014;42: D1001-6.
41. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011;39:D945-50.
42. Becker KG, Barnes KC, Bright TJ, et al. The genetic association database. Nat Genet 2004;36: 431-2.
43. Purcell AW, Elliott T. Molecular machinations of the MHC-I peptide loading complex. Curr Opin Immunol 2008;20:75-81.
44. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-68.